August 20th, 2020. Rose City Labs Adopts Medicinal Genomics’ qPCR Technology for Cannabis Testing Rose City Labs, a multistate state operating organization, has selected Medicinal Genomics’ PathoSEEK® qPCR platform for microbial testing in its Portland, OR, facility, the first in that state.
July 30th, 2020 SD PharmLabs, First Hemp Lab in Texas, Selects Medicinal Genomics for Microbial Testing SD PharmLabs, a multistate testing lab organization, has selected Medicinal Genomics’ PathoSEEK® qPCR platform for microbial testing in its Texas hemp lab, the first in that state.
March 10, 2020 – Medicinal Genomics Signs on as Agilent US Value Added Reseller MGC will sell Agilent’s Aria qPCR instruments and Bravo, Agilent’s liquid handling DNA purification and lab automation platform in the U.S
March 9th 2020 Revolutionising cannabis cultivation with world-first SNP chip The word’s-first SNP chip has been developed to help breeders with cultivation by improving the consistency of chemical profiling and disease resistant characteristics of cannabis crops, as well as helping to meet regulation for THC levels.
June 14th 2020 – Cannabis plant may harbor SARS-CoV-2 for at least a week Researchers at the Medicinal Genomics Corporation have warned that cannabis flowers exposed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may harbor the virus for at least seven days.
April 6, 2020 – Cannabis and Coronavirus: Help Keeps Coming from Industry Businesses – Medicinal Genomics Corp. (MGC) has pledged proceeds from ticket sales for its CannMed 2020 tradeshow, will be donated to pandemic relief.
March 3, 2020 – Pharmaceutical company claims to have developed a cannabis treatment for coronavirus symptoms – Kevin McKernan, founder of Massachusetts-based life sciences company, Medicinal Genomics, tweeted, “Bummer. There is actually some exciting preliminary work on cannabinoids and viruses that are now getting sold before it’s (…) understood.”
January 29, 2020 – Arbor Biosciences, Biosearch Technologies Ink Global Distribution Deal for Ag-Bio NGS Panels – Over the last year, the firm has formed partnerships with Curio Genomics on bioinformatics for a wheat exome panel and with Medicinal Genomics for a cannabis genotyping panel.